Clinical Trial Update: Dual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 2 study evaluating dual targeting of VEGF-A and angiopoietins in chemotherapy-naïve metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Austin Health | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN